Number of the records: 1
Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect
SYS 0540798 LBL 01000a^^22220027750^450 005 20240103225552.8 014 $a 85101228033 $2 SCOPUS 014 $a 000620445500001 $2 WOS 017 70
$a 10.1080/2162402X.2021.1880046 $2 DOI 100 $a 20210308d m y slo 03 ba 101 $a eng $d eng 102 $a US 200 1-
$a Efficiency of human monocyte-derived suppressor cell-based treatment in graft-versus-host disease prevention while preserving graft-versus-leukemia effect 215 $a 11 s. 463 -1
$1 001 cav_un_epca*0430854 $1 011 $a 2162-4011 $1 200 1 $a OncoImmunology $v Roč. 10, č. 1 (2021) $1 210 $c Landes Bioscience 608 $a Article 610 $a graft-versus-host disease 610 $a graft-versus-leukemia effect 610 $a human monocyte-derived suppressor cells 610 $a immunosuppressive drugs 610 $a inflammation 610 $a regulatory T cells 700 -1
$3 cav_un_auth*0406862 $a Janikashvili $b N. $y FR $4 070 701 -1
$3 cav_un_auth*0406863 $a Gérard $b C. $y FR $4 070 701 -1
$3 cav_un_auth*0406864 $a Thébault $b M. $y FR $4 070 701 -1
$3 cav_un_auth*0380597 $a Brázdová $b Andrea $p UOCHB-X $i Vyléčení hepatitidy B $j HBV Cure $k 790/79 $l 790/79 $y CZ $4 070 $T Ústav organické chemie a biochemie AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0406865 $a Boibessot $b C. $y FR $4 070 701 -1
$3 cav_un_auth*0406866 $a Cladière $b C. $y FR $4 070 701 -1
$3 cav_un_auth*0406867 $a Ciudad $b M. $y FR $4 070 701 -1
$3 cav_un_auth*0406868 $a Greigert $b H. $y FR $4 070 701 -1
$3 cav_un_auth*0406869 $a Ouandji $b S. $y FR $4 070 701 -1
$3 cav_un_auth*0406870 $a Ghesquière $b T. $y FR $4 070 701 -1
$3 cav_un_auth*0406871 $a Samson $b M. $y FR $4 070 701 -1
$3 cav_un_auth*0406872 $a Audia $b S. $y FR $4 070 701 -1
$3 cav_un_auth*0406873 $a Saas $b P. $y FR $4 070 701 -1
$3 cav_un_auth*0406874 $a Bonnotte $b B. $y FR $4 070 $z K 856 $u https://doi.org/10.1080/2162402X.2021.1880046 $9 RIV
Number of the records: 1